Adverse events in studies of classic psychedelics: A systematic review and meta-analysis

JT Hinkle, M Graziosi, SM Nayak, DB Yaden - JAMA psychiatry, 2024 - jamanetwork.com
Importance A clear and comprehensive understanding of risks associated with psychedelic-
assisted therapy is necessary as investigators extend its application to new populations and …

History repeating: guidelines to address common problems in psychedelic science

M van Elk, EI Fried - Therapeutic Advances in …, 2023 - journals.sagepub.com
Research in the last decade has expressed considerable optimism about the clinical
potential of psychedelics for the treatment of mental disorders. This optimism is reflected in …

Psilocybin-assisted therapy for depression: A systematic review and meta-analysis

S Haikazian, DCJ Chen-Li, DE Johnson, F Fancy… - Psychiatry …, 2023 - Elsevier
The aim of this review was to determine the effect of psilocybin on depressive symptoms in
patients diagnosed with life-threatening illnesses or major depressive disorder. Systematic …

How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change

RJ Zeifman, AC Wagner, CM Monson… - Journal of Affective …, 2023 - Elsevier
Background Psilocybin therapy is receiving attention as a mental health intervention with
transdiagnostic potential. In line with psychotherapeutic research, qualitative research has …

Psilocybin history, action and reaction: a narrative clinical review

P Sharma, QA Nguyen, SJ Matthews… - Journal of …, 2023 - journals.sagepub.com
Hallucinogenic mushrooms have been used in religious and cultural ceremonies for
centuries. Of late, psilocybin, the psychoactive compound in hallucinogenic mushrooms, has …

Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?

K Hashimoto - European Archives of Psychiatry and Clinical …, 2024 - Springer
The growing interest in the rapid and sustained antidepressant effects of the dissociative
anesthetic ketamine and classic psychedelics, such as psilocybin, is remarkable. However …

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression

B Weiss, I Ginige, L Shannon, B Giribaldi… - Psychological …, 2024 - cambridge.org
BackgroundPsilocybin Therapy (PT) is being increasingly studied as a psychiatric
intervention. Personality relates to mental health and can be used to probe the nature of PT's …

Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use

N Gukasyan, RR Griffiths, DB Yaden… - Journal of …, 2023 - journals.sagepub.com
Background: Psilocybin is being studied for depression, but little is known about how it
interacts with common antidepressants. Limited data suggest that psilocybin's effects may be …

[HTML][HTML] Serotonergic Psychedelics–a Comparative review Comparing the Efficacy, Safety, Pharmacokinetics and Binding Profile of Serotonergic Psychedelics

F Holze, N Singh, ME Liechti, DC D'Souza - … : Cognitive Neuroscience and …, 2024 - Elsevier
Psychedelic compounds, including psilocybin, LSD, DMT, and 5-MeO-DMT all of which are
serotonin (5-HT) 2A receptor agonists are being investigated as potential treatments. This …

Ethnoracial inclusion in clinical trials of psychedelics: a systematic review

ME Hughes, A Garcia-Romeu - EClinicalMedicine, 2024 - thelancet.com
Background Prior data indicate limited ethnoracial diversity in studies testing psychedelic-
assisted treatments. Regulatory approval for psychedelic treatments may be imminent given …